Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters. Geisler A, Dieringer B, Elsner L, Klingel K, Klopfleisch R, Vornlocher HP, Kurreck J, Fechner H. Molecular Therapy Nucleis Acids, 2023, Volume 32, P923-936. Read Article.
Axolabs is the leading service provider for the discovery, development and manufacture of therapeutics based on DNA or RNA.
Programmierung und technische Betreuung
AS-DESIGN.Werbeagentur GmbH
